Director/PDMR Shareholding

RNS Number : 4403C

Hikma Pharmaceuticals Plc

13 April 2017

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Michael Raya
2	Reason for the notification
a)	Position/status	CEO of West-Ward Pharmaceuticals
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Further Shares disposed from vesting of the conditional awards on 10 April 2017 under the 2014 Executive Incentive Plan (EIP). An additional 2,370 shares were sold to cover tax and associated costs resulting in 9,383 shares being retained.
c)	Price(s) and volume(s)	Price Volume(s) £19.42 2,370 £0.00 9,383
d)	Aggregated information	£19.42 £46,025
e)	Date of the transaction	12 April 2017
f)	Place of the transaction	London Stock Exchange (XLON)

 

END

 

 

DSHGRGDSLUBBGRX